Skip to main content
SpringerLink
Log in

Role of heat stable fraction of alkaline phosphatase as an adjunct to ca 125 in monitoring patients of epithelial ovarian carcinoma

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Heat stable fraction (HSF) of alkaline phosphatase (ALP) was evaluated as an adjunct to CA 125 as a tumour marker for epithelial ovarian cancer in a follow-up study. In our study group 63.4% of patients had elevated HSF levels (≥10U/L) and 93.3% had elevated CA 125 levels (>35U/mL). The sensitivity of CA 125 and HSF was 93.3% and 63.3% respectively. The decline in the activity of HSF, over the pre-op levels was highly significant after the first (p=0.001) chemotherapy cycle and significant after the second and third cycles (p<0.029). Thereafter, HSF activity was almost undetectable. The decrease in CA 125 levels over the pre-op levels was significant after the first, second, third (p<0.001) and fourth (p<0.034) chemotherapy cycle. HSF can be used alone or as an adjunct to CA 125 in screening and monitoring patients of ovarian carcinoma especially in remote areas where sophisticated facilities are not available and in patients in which CA 125 levels are not raised preoperatively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Haije, W.G. (1982) Biochemical markers in ovarian cancer: possibilities and limitations. Ann. Clin. Biochem. 19, 258–262.

    PubMed  Google Scholar 

  2. Tammela, J. and Lele, S. (2004) New modalities in detection of recurrent ovarian cancer. Curr. Opin. Obstet. Gynecol. 16, 5–9.

    Article  PubMed  Google Scholar 

  3. Thakur, V., Anand, A.K., Mukherjee, U. and Ghosh, D. (2003) Determination of cancer antigen 125 in ovarian carcinoma. Indian J. Clin. Biochem. 18, 27–33.

    CAS  Google Scholar 

  4. Nouwen, E.J., Pollet, D.E., Schelstraete, J.B.,et al. (1985) Human placental alkaline phosphatase in benign and malignant ovarian neoplasia. Cancer Res. 45, 3244–3247.

    Google Scholar 

  5. FIGO Cancer Committee. (1986) Stage grouping for primary carcinoma of ovary. Gynecol. Oncol. 25, 383–385.

    Article  Google Scholar 

  6. Serov, S.F., Scully, R.E. and Sorbin, L.H. (1973) Histological typing of ovarian tumours In: International Histological Classification of Tumours Geneva, Switzerland: World Health Organization. 17–18.

    Google Scholar 

  7. Fishman, W.H., Bardawil, W.A., Habibm, H.G., Anstiss, C.L. and Green, S. (1962) The placental isoenzyme of alkaline phosphatase in sera of normal pregnancy. Am. J. Clin. Pathol. 57, 65.

    Google Scholar 

  8. Hausamen, T.U., Helger, R., Rick, W. and Gross, W. (1967) Optimal conditions for the determination of serum alkaline phosphatase by a new kinetic method. Clin. Chim. Acta. 15, 241–245.

    Article  CAS  Google Scholar 

  9. Young, R.C., Perez, C.A. and Hoskins, W.J. (1993) Cancer of the ovary. Cancer Principles and Practice of oncology. Philadelphia: J B Lippincott Company 5, 1226–1263.

    Google Scholar 

  10. Joly, D.J., Lilienfeld, A.M., Diamond, E.L., Bross, I.D. (1974) An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am. J. Epidemiol. 99, 190–209.

    PubMed  CAS  Google Scholar 

  11. Beral, V., Fraser, P. and Chilvers, C. (1978) Does pregnancy protect against ovarian cancer? Lancet 1, 1083–1087.

    Article  PubMed  CAS  Google Scholar 

  12. Silveston, A., Tobias, J.S. and Benjamin, E. (1997) Gynecologic oncology, Mosby Wolfe, U.K., 1–8.

    Google Scholar 

  13. Nozawa, S., Udagawa, Y., Ohkura, H.,et al. (1989) Serum placental alkaline phosphatase (PLAP) in gynaecologic malignancies with special reference to the combination of PLAP and CA54/61 assay. Clin. Chem. Acta. 186, 275–284.

    Article  Google Scholar 

  14. Ward, B.G., Gruickshank, D.J., Tucker, D.F. and Love, S. (1987) Independent expression in serum of three tumour-associated antigens: CA125, placental alkaline phosphatase and HMF G2 in ovarian carcinoma. Br. J. Obstet. Gynaecol. 94, 696–698.

    PubMed  CAS  Google Scholar 

  15. Bast, R.C., Knauf, S., Epenetos, A.,et al. (1991) Coordinate elevation of serum markers in ovarian cancer but not in benign disease. Cancer 68, 1758–1763.

    Article  PubMed  Google Scholar 

  16. Vergote, I.B., Bormer, O.P. and Abeler, V.M. (1987) Evaluation of serum CA 125 levels in the monitoring of ovarian cancer. Am. J. Obstet. Gynecol. 157, 88–92.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Biochemistry, Lady Hardinge Medical College and Smt. Sucheta Kriplani Hospital, New Delhi, India

    P. K. Nigam (Consultant Biochemist), A. Jain & P. Goyal

  2. Dept. of Obstetrics and Gynecology, Lady Hardinge Medical College and Smt. Sucheta Kriplani Hospital, New Delhi, India

    R. Chitra

Authors
  1. P. K. Nigam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Chitra
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nigam, P.K., Jain, A., Goyal, P. et al. Role of heat stable fraction of alkaline phosphatase as an adjunct to ca 125 in monitoring patients of epithelial ovarian carcinoma. Indian J Clin Biochem 20, 43–47 (2005). https://doi.org/10.1007/BF02867399

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02867399

Key Words

Search

Navigation